Patent · US Expired

2-halo-2'-deoxyadenosine treatment for histiocytosis

US5510336A · kind A · utility

23Cited by

4References

12Claims

0Family size

Inventors

Alan Saven · San Diego, US
Lawrence D. Piro · Village of La Jolla, US

Key dates

Filing date	Sep 6, 1994
Grant date	Apr 23, 1996
Priority date	—
Expiry date	Sep 6, 2014

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/7076
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An improved method for treating Class I histiocytosis, Langerhans cell histiocytosis, is disclosed. In accordance with that method, a therapeutically effective amount of a 2-halo-2'-deoxyadenosine is administered to a host mammal such as a human patient having histiocytosis in an amount of about 0.5 to 0.9 mg/kg of body weight over a course of about 5 to 9 days for up to two courses.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.